The Digital Twin in Clinical Research
Digital twins of assets and processes are established by using Internet of Things (IoT) technology to acquire massive amounts of…
Digital twins of assets and processes are established by using Internet of Things (IoT) technology to acquire massive amounts of…
Research scientists know that data alone does not lie – but data can mislead. That’s especially true in clinical trials…
The US Food and Drug Administration (FDA) recently revisited the topic of drugs for liver infection through a newly issued…
Providing annual reviews on IDMP progress has proved painful in recent years because momentum has not always been where it…
Healthcare mergers and acquisitions have been the cause of extensive debate across the medical industry, calling into question the tools…
Improving experimental drug success rate and accelerating clinical development are top priorities for pharmaceutical and biotech companies. Careful and considered…
2019 saw many noteworthy changes in the regulatory industry. In April 2019 it was announced that the FDA’s Office of…
Although previously very rare, more and more trials are becoming in need of ‘rescue’ as competition for resources means less…
A critical part of managing clinical trials is a solid, well thought out clinical trial budget. A successful budget to…
With the recent advent of adeno-associated, virus-based gene therapy treatments, limb girdle muscular dystrophy (LGMD) is currently attracting the attention…